What's New
SGLT2 Inhibitors and GLP-1 Receptor AgonistsJanuary 3, 2024
SGLT2 inhibitors and GLP1 receptor agonists are being used increasingly in NZ for type 2 diabetes and other conditions such as heart failure and obesity. This bulletin gives an overview of these two classes of medicines.
MedSafetyWeek – 6 to 12 November 2023 – Who can report?November 7, 2023
This week is #MedSafetyWeek! The goal this year is to get patients and healthcare professionals to report suspected side effects of medicines. Whether you’re a patient, pharmacist, doctor, nurse, or other healthcare professional, you can help make medicines safer by reporting side effects to CARM (Centre for Adverse Reactions Monitoring) at https://pophealth.my.site.com/carmreportnz/s/. Providing high-quality patient […]
World AMR Awareness Week (WAAW) 18 – 24 November 2023October 19, 2023
Antimicrobial resistance (AMR) is a global crisis, slower burning than COVID-19 but potentially as catastrophic. It is a growing problem in Aotearoa New Zealand and may cost us dearly: longer hospital stays, poorer outcomes from interventions like surgery and cancer-related care, increased mortality, and elevated healthcare costs. AMR will disproportionately impact the most socioeconomically disadvantaged […]
Credible (and free) medicines information resourcesAugust 18, 2023
It can be challenging to find reliable information on medicines. Check out our Useful Links page for a list of freely-available online medicines information resources.